ADMA Biologics ADMA Increase (Decrease) in Inventories
Increase (Decrease) in Inventories at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's increase (decrease) in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's increase (decrease) in inventories?
- ADMA Biologics (ADMA) reported increase (decrease) in inventories of $15.63M in Q1 2026.
- How has ADMA Biologics's increase (decrease) in inventories changed year-over-year?
- ADMA Biologics's increase (decrease) in inventories increased by 700.5% year-over-year, from $1.95M to $15.63M.
- What is the long-term trend for ADMA Biologics's increase (decrease) in inventories?
- Over 4 years (2021 to 2025), ADMA Biologics's increase (decrease) in inventories has grown at a -4.3% compound annual growth rate (CAGR), from $43.19M to $36.23M.
- What does increase (decrease) in inventories mean?
- Reflects the net change in the value of raw materials, work-in-progress, and finished goods held by the company. Monitoring this helps assess inventory management efficiency and potential risks related to product obsolescence or supply chain imbalances.